Loading provider…
Loading provider…
Dermatology Physician in Santa Monica, CA
NPI: 1003922162Primary Employer
Ava T Shamban MD Inc
avamd.com
HQ Phone
Get MD Ava's Phone Numberphone_androidMobile
Get MD Ava's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1983 - 2027
CO State Medical License
2017 - 2027
NV State Medical License
2018 - 2027
NY State Medical License
2009 - 2027
HI State Medical License
2009 - 2026
IL State Medical License
2014 - 2026
TN State Medical License
2022 - 2025

American Board of Dermatology
Dermatology
Cleveland Medical College, Homeopathic
case.edu
Medical School
Until 1982
Los Angeles County-Harbor-UCLA Medical Center
Residency • Dermatology
1987 - 1989
The MetroHealth System/Case Western Reserve University
Internship • Internal Medicine
1982 - 1983
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 209 | 580 |
| 2 | 17000Destruction of skin growth | 118 | 199 |
| 3 | 17110Destruction of up to 14 skin growths | 112 | 195 |
| 4 | 17003Destruction of 2-14 skin growths | 86 | 361 |
| 5 | 11102Tangential biopsy of single skin lesion | 74 | 97 |
Authors: Alexander Rivkin, Steven Dayan, Michael Kaminer, Joel Cohen, Craig Teller, Joel Cohen, Susan Weinkle, Jonathan Sykes
Journal: Dermatol Surg
The Aging neck-A Case base treatment algorithm.
Authors: Sabrina Fabi
Publication Date: 2020-10-14
Authors: Brian Biesman, Doris Day, Joel Cohen, Suneel Chilukuri
Journal: J Cosmet Dermatol
Lead Sponsor: Croma-Pharma GmbH
Collaborators: Syneos Health
Intervention / Treatment: DEVICE: Princess Filler Lidocaine
Lead Sponsor: Evolus, Inc.
Intervention / Treatment: BIOLOGICAL: Botulinum purified neurotoxin, Type A
Lead Sponsor: ATS Clinical Research
Collaborators: Allergan
Intervention / Treatment: DRUG: Track B, DRUG: Track A